FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 94 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,000 | +200.0% | 87 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 87 | -45.6% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 160 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 160 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 160 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 160 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,092,152 | $16,808,219,000 | 9.64% |
| GREAT POINT PARTNERS LLC | 1,226,785 | $18,880,000 | 7.47% |
| Ghost Tree Capital, LLC | 500,000 | $7,695,000 | 3.46% |
| RTW INVESTMENTS, LP | 713,954 | $10,988,000 | 3.41% |
| ARMISTICE CAPITAL, LLC | 506,000 | $7,787,000 | 2.66% |
| EcoR1 Capital, LLC | 149,000 | $2,293,000 | 1.04% |
| Eventide Asset Management | 1,164,900 | $17,928,000 | 1.04% |
| Telemetry Investments, L.L.C. | 102,500 | $1,577,000 | 0.68% |
| J. Goldman & Co LP | 313,527 | $4,825,000 | 0.41% |
| AWM Investment Company, Inc. | 118,199 | $1,819,000 | 0.35% |